ABSTRACT. Maternofetal clearance of 45Ca and "Cr-EDTA (diffusional marker) were simultaneously measured across in situ perfused placentas of intrauterine growthretarded (IUGR) and control rat fetuses on d 20 of gestation. IUGR was induced by uterine artery and vein ligation on d 17 of gestation. Control fetuses and their placentas were taken from sham-operated dams. We hypothesized that calcium transfer would be impaired across placentas of IUGR fetuses. The mean body wt of IUGR fetuses was 42% lower, and the mean nose-anus length was 16% lower than those of control fetuses. The mean total calcium content of IUGR fetuses was significantly lower than that of control fetuses, but not when it was normalized to body wt. The mean maternal whole blood ionized calcium concentration was not significantly different in the two groups. The materno-fetal clearance of 45Ca across IUGR placentas was significantly lower than that across control placentas (IUGR = 35.2 + 1.9 pL/min/g placenta, mean + SEM; control = 93.1 + 12 pl/min/g placenta, p < 0.002). In contrast, the maternofetal clearance of "Cr-EDTA, the reference diffusional marker, was not significantly different across IUGR and control placentas. We conclude that maternofetal transfer of calcium is reduced across placentas of IUGR rat fetuses. (Pediatr Res 25420-422, 1989)
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Abbreviation

IUGR, intrauterine growth retardation
The placenta transfers large quantities of calcium to meet the demands of the rapidly mineralizing fetus. This transfer occurs mainly in the last third of pregnancy and is believed to involve active transport mechanisms as it takes place against a concentration gradient (1).
Evidence for reduced placental calcium transfer in IUGR comes from a study by Minton et al. (2) , who reported a significantly reduced bone mineral content as measured by photon absorptiometry in IUGR, compared with appropriately grown infants of similar gestational age. To the best of our knowledge, there have been no direct measurements of calcium transfer across placentas of IUGR fetuses. In this study, the Rcce~vcd May 13, 1988 maternofetal clearance of 45Ca and 51Cr-EDTA were simultaneously measured across in situ perfused placentas of IUGR and control rat fetuses, 51Cr-EDTA being used to provide a measure of maternofetal transfer by diffusion. IUGR was induced by uterine artery and vein ligation (3), and sham-operated dams served as controls. We hypothesized that the maternofetal transfer of calcium would be impaired across placentas of IUGR fetuses.
MATERIALS AND METHODS
Materials. All chemicals were reagent grade, and were purchased from Sigma Chemical Co. (St. Louis, MO). Radioisotopes and Aqu~sol I1 liquid scintillation cocktail were purchased from New England Nuclear (Boston, MA).
Animals and surgical procedure. Time-mated Sprague-Dawley rats were purchased from Zivic Millar Lab Inc. (Allison Park, PA) on d 14 of gestation. They were housed in individual cages and allowed free access to water and Purina Rat Chow (RalstonPurina Co., St. Louis, MO). On d 17 of gestation (term = 22 d), a low midline laparotomy was performed under methoxyflurane anesthesia (Metofane, Pitman-Moore Inc., Washington Crossing, NJ). In rats with five or more conceptuses in each uterine horn, uterine vessels (artery and vein) to both the horns were ligated at the level of the cervix using 4-0 silk ligatures. The abdominal incisions were closed with 3-0 silk sutures, and the animals were allowed to recover. Sham-operated animals had the same vessels exposed but not ligated and the same duration of anesthesia as the experimental group. The total duration of surgery was approximately 20 min in each animal.
Placental perfusion. Details of the in situ placental perfusion technique, which is modified from the original description of Stulc et al. (4) has been described elsewhere (5) . A schematic diagram of the perfusion system is shown in Figure 1 . Briefly, on d 20 of gestation, the dams were anesthetized with 110 mg/ kg sodium thiobutabarbitol injected intrapentoneally. The maternal rectal temperature was maintained at 37°C throughout the experiment. A maternal jugular vein was cannulated for injection of tracers, and a carotid artery for blood pressure monitoring and blood sampling. After laparotomy and hysterotomy, one of the fetuses was delivered. Modified Krebs-Ringer solution containing NaCl 118 mM, KC1 4.7 mM, CaCI2 1.25 mM, KH2P04 1.18 mM, MgS04 1.18 mM, NaHC03 25 mM, glucose 1 1 mM, and 3.5% dextran (40 000 mol wt), was gassed continuously with a mixture of 95% 0 2 and 5% CO2 at 37°C and pumped by a peristaltic pump (Hake-Buchler, Saddle Brook, NJ) into the fetal circulation of the placenta, via a cannula in the umbilical artery. The perfusion rate varied from 0.28 to 0.39 mL/min between experiments, but remained constant during any individual experiment. After a single pass through the placenta, perfusate effluent was collected from a cannula in the umbilical vein. Statistics. The data are presented as mean + SEM, and the difference between means in each group were analyzed using Student's t test for unpaired samples.
R E S U L T S
The data on fetal wt and nose-anus length, placental wt, and total calcium content of fetuses whose placentas were perfused are summarized in Table 1 .
The mean maternofetal clearance of 45Ca across placentas of IUGR fetuses was 35.2 k 1.9 pL/min/g placenta, which was significantly ( p < 0.002) lower than the mean value of 93.1 k 12 pL/min/g placenta across placentas of control fetuses. In contrast, the maternofetal clearance of "Cr-EDTA across the IUGR placentas (5.7 + 1.0 pL/min/g placenta) was not significantly different from that across control placentas (4.7 + 0.5 pL/ min/g placenta). The mean maternal whole blood ionized calcium concentrations in IUGR and the controls was not significantly different at 1.34 + 0.06, and 1.24 + 0.05 mmol/L respectively.
The mean maternal blood pressure during placental perfusion in the IUGR group (97.6 + 8.2 mm Hg) was not significantly different from that in the control group (83.6 + 7.9 mm Hg). The mean perfusion pressure in the IUGR group was 16.6 + 1.7 mm Hg, which was not significantly different from that in the fUGR group, 14.1 t 3.3 mm Hg.
DISCUSSION
In the classical Wigglesworth model (3). fetal growth retardation was experimentally induced in one uterine horn by uterine artery and vein ligation, and fetuses in the contralateral horn served as controls. We used a protocol suggested by Kollee et al. (6) , in which IUGR fetuses were taken from dams with bilateral uterine vessel ligation and controls from sham-operated animals, because the latter investigators reported increased variability in wt and aberrant carbohydrate metabolism in control fetuses from the contralateral horn of the Wigglesworth model. Maternofetal 4'Ca clearance across the in situ perfused rat placenta has been previously demonstrated to be only slightly lower than the in vivo clearance across placentas of both anesthetised and nonanesthetised intact animals (4). The results of the present perfusion study indicate that the maternofetal clearance of 45Ca was strikingly reduced across placentas of IUGR fetuses; by contrast, clearance of "Cr-EDTA was unchanged. In the absence of a significant difference in maternal whole blood ionized calcium concentration between the two groups, a fall in 45Ca clearance across IUGR placentas is consistent with a fall in maternofetal calcium flux in the latter.
The mechanism by which ligation of uterine blood vessels results in reduced placental calcium transfer is not known. However, it is unlikely to be due to decreased saturation of the maternofetal calcium transporting system because of the unchanged maternal whole blood ionized calcium concentrations. A decreased placental "porosity" or surface areas is also unlikely because of the unchanged maternofetal "Cr-EDTA clearance.
Flow limitation in the supply of calcium at the maternal face of the placenta is also unlikely (7) but has not been rigorously excluded, especially after uterine artery ligation.
In mammals, it is widely believed that placental calcium transfer in the maternofetal direction involves active transfer process, as it takes place against a concentration gradient, both in vivo (1) and across the in situ perfused placenta (4, 8, 9) . The mechanisms involved in placental calcium transfer are not fully known. From studies involving uptake of 45Ca by vesicles prepared from microvilli and microsomal membranes of the human placenta (lo), it has been suggested that hydrolysis of ATP may provide a source of energy for the placental "calcium transporting pump." For example, the ovine uteroplacental unit consumes approximately 45% of uterine oxygen uptake and approximately 72% of the glucose delivered to it (1 1). Although part of the glucose extracted by the fetoplacental unit is converted to lactate in this species, the bulk of the glucose and oxygen is likely to be utilized for placental metabolic activity. Thus, chronic reduction in utroplacental blood flow might result in depletion of the necessary energy supply for active transport across IUGR placentas.
Factors regulating placental calcium transfer are not known, but they are likely to be hormonal as the placenta has no nerve supply. In experimentally growth-retarded lambs, fetal serum concentration of such hormones as insulin, thyroxin and prolactin are decreased compared with control fetuses (12) . In the sheep, there is indirect evidence that 1,25 dihydroxyvitamin D, the hormonal form of vitamin D, produced by the fetus may regulate placental calcium transfer (1 3). Thus, impaired production of hormones regulating placental transfer in utero may speculatively be another possible mechanism for impaired calcium transfer across placentas of IUGR fetuses.
